Skip to main content

Genus Capital Management Inc.

Position in NVS — Novartis AG

CIK 1532385 VANCOUVER, A1

Position in NVS

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$237,831
-$58,865 QoQ
Shares Held
1,557
-27.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$281,712
PutShares
2,895

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $237,831 1,557
2025-12-31 $296,696 2,152
2025-09-30 $451,661 3,522
2025-06-30 $373,799 3,089
2025-03-31 $322,734 2,895
2024-12-31 $281,712 2,895
2024-09-30 $1,526,775 13,274
2024-06-30 $449,048 4,218
2024-03-31 $461,498 4,771